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(57) ABSTRACT 
The present invention provides materials and methods 
related to causing insect resistance in plants. Speci?cally, the 
present invention provides nucleic acid compounds Which 
encode a teratocyte secreted protein (TSP) Which is capable 
of causing inhibition of groWth and developmental arrest in 
Lepidoptera larvae. Cells and plants (including plant parts, 
seeds, embryos, etc.) comprising the nucleic acid com 
pounds are also Within the scope of the present invention. 
The present invention also provides amino acid compounds 
encoded by the nucleic acid compounds of the present 
invention, as Well as methods to induce larval developmen 
tal arrest, methods to produce the nucleic acid and amino 
acid compounds, and methods to inhibit crop damage due to 
Lepidoptera infestation. 
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MATERIALS AND METHODS USEFUL TO 
AFFECT GROWTH AND DEVELOPMENT OF 
LEPIDOPTERA LARVAE 
BACKGROUND OF THE INVENTION 
Parasites of plant-eating insects are natural pesticides. 
One such solitary parasite, Microplitis croceipes (a member 
of the Wasp family Braconidae), causes inhibition of growth 
and permanent developmental arrest of the tobacco 
budWorm, the cotton bollWorm (also knoWn as the corn 
earWorm and tomato fruitWorm) and the soybean pod Worm. 
The larvae of these insects (Heliothis and Helicoverpa spp.) 
feed on tobacco, cotton, maiZe, sorghum, soybeans, sun 
?oWer and tomatoes, among other plants. The larvae cause 
economic losses of over $1 billion annually, primarily in the 
form of yield reduction and costs related to control. Fitt, 34 
Ann. Rev. Entomol. 17 (1989). 
In the past, the United States Department of Agriculture 
has funded programs designed to increase Microplitis cro 
ceipes populations in Southern states so as to naturally 
combat these pests in those areas. These efforts Were suc 
cessful in reducing pest populations. Use of such “bioman 
agement” techniques has generally been replaced With 
molecular biology techniques, such as those Which alloWed 
engineering of plants Which express Bacillus thuringiensis 
toxin. 
Certain extra-embryonic cells (teratocytes) from M. cro 
ceipes have been shoWn to be involved in impairment of the 
groWth, development and related physiological parameters 
of Heliothis and Helicoverpa larvae. Although teratocytes do 
not undergo cell division subsequent to their release into the 
hemocoel of the host, they do become polyploidal. Injection 
of one larval equivalent of teratocytes caused characteristic 
post-Wandering, pre-pupation developmental arrest and 
eventual death associated With parasitiZation. Zhang and 
Dahlman, 12 Arch. Insect Biochem. Physiol. 51 (1989). 
Teratocytes collected from M. croceipes eggs hatched in 
vitro produced responses similar to those collected from 
parasitiZed Heliothis larvae. Zhang et al., 43 J. Insect 
Physiol. 577 (1997). Furthermore, it has been suggested that 
When teratocytes are cultured in vitro, they secrete a mixture 
of proteins (teratocyte secreted proteins or TSP) Which, 
When injected into host larvae, produced responses similar 
to parasitiZation. Schepers et al., 44 J. Insect Physiol. 767 
(1998). 
In related studies, juvenile hormone esterase and ecdys 
one titers have been shoWn to be suppressed by teratocytes 
to a degree similar to those in parasitiZed larvae. Zhang, et 
al. 20, Arch. Insect Biochem. Physiol. 231 (1992). Reduced 
titers of host hemolymph proteins have been observed, 
particularly in older stages, With a major effect on the 74, 76 
and 82 kD storage protein monomers. Zhang et al., 43 J. 
Insect Physiol. 577 (1997). Inhibition of storage protein 
synthesis in the fat body Was theoriZed to be at the level of 
translation, primarily based on the ?nding that storage 
protein mRNA levels did not change, even though protein 
synthesis declined precipitously after treatment With terato 
cytes. Dong et al., 32 Arch. Insect Biochem. Physiol. 237 
(1996). 
Citation of the above documents is not intended as an 
admission that any of the foregoing is pertinent prior art. All 
statements as to the date or representation as to the contents 
of these documents is based on subjective characterization 
of information available to the applicant, and does not 
constitute any admission as to the accuracy of the dates or 








SUMMARY OF THE INVENTION 
It is therefore an object of the present invention to provide 
isolated nucleic acid compounds useful to inhibit insect 
larval groWth and development. 
It is a further object to provide isolated amino acid 
compounds useful to inhibit larval groWth and development. 
It is yet another object to provide methods to produce 
isolated amino acid compounds useful to inhibit larval 
groWth and development. 
It is yet another object to provide methods to inhibit larval 
groWth and development. 
In all of the above embodiments, it is an object to provide 
methods to reduce crop damage using the compounds and 
methods herein. 
It is an object of the invention to provide a natural 
pesticide using the compounds and methods herein. 
It is an object of the invention to provide vectors, cells and 
molecular constructs comprising the compounds and meth 
ods herein. 
It is an object of the invention to provide plants, including 
plant parts, seeds and embryos comprising the compounds 
and methods herein. 
De?nitions: 
For the purposes of the present application, the folloWing 
terms have the folloWing meanings. All other terms have the 
meaning as generally recogniZed in the art. 
“Allelic variant” is meant to refer to a gene that occurs at 
essentially the same locus (or loci) as the referent sequence, 
but Which, due to natural variations caused by, for example, 
mutation or recombination, has a similar but not identical 
sequence. Allelic variants typically encode proteins having 
similar activity to that of the protein encoded by the gene to 
Which they are being compared. Allelic variants can also 
comprise alterations in the 5 ‘ or 3‘ untranslated regions of the 
gene (e.g., in regulatory control regions). 
“Fragment” is meant to refer to any nucleic acid or 
polypeptide subset of the referent compound. 
“Inducing agent” means any compound or condition that 
causes inducement of an inducible promoter, including 
chemical compounds or environmental conditions, such as 
drought, Wounds, light cycle, etc. 
“Maize” and “corn” shall be interchangeable and mean all 
maiZe varieties. 
“Proteins” means any compounds Which comprise amino 
acids, including peptides, polypeptides, fusion proteins, etc. 
“Transform” means delivery of nucleic acid into a cell, 
including delivery Which results in genomic integration and 
delivery Which results in transient localiZation Within the 
cell membrane. 
Moreover, for the purposes of the present invention, the 
term “a” or “an” entity refers to one or more of that entity; 
for example, “a protein” or “a nucleic acid molecule” refers 
to one or more of those compounds or at least one com 
pound. As such, the terms “a” (or “an”), “one or more” and 
“at least one” can be used interchangeably herein. It is also 
to be noted that the terms “comprising”, “including”, and 
“having” can be used interchangeably. Furthermore, a com 
pound “selected from the group consisting of” refers to one 
or more of the compounds in the list that folloWs, including 
mixtures (i.e., combinations) of tWo or more of the com 
pounds. According to the present invention, an isolated, or 
biologically pure, protein or nucleic acid molecule is a 
compound that has been removed from its natural milieu. As 
such, “isolated” and “biologically pure” do not necessarily 
re?ect the extent to Which the compound has been puri?ed. 
US 6,337,432 B1 
3 
An isolated compound of the present invention can be 
obtained from its natural source, can be produced using 
molecular biology techniques or can be produced by chemi 
cal synthesis. 
BRIEF DESCRIPTION OF THE TABLES 
Table 1—Sequence listing of cDNAs, peptides and prim 
ers. 
Table 2—Responses of Heliothis virescens larvae to feed 
ing on transgenic plants expressing the TSP gene. 
Table 3—Responses of Manduca sexta larvae to feeding 
on transgenic plants expressing the TSP gene. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 shoWs that When the recombinant TSP Was tested 
With a rabbit reticulocyte lysate assay an inverse dose 
dependent effect Was observed over a range of 0.2—0.8 pg 
protein/25 pL, shoWing that TSP inhibits protein synthesis. 
FIG. 2 shoWs a schematic map of the plant expression 
vectors constructed for expressing the chimeric TSP gene 
With its oWn signal peptide (pKT117) and Without any signal 
peptide (pKT118); and With signal peptide from the PR1b 
protein (pKT119), shoWing the coding sequence directed by 
the peanut chlorotic streak virus full-length transcript pro 
moter (2><enh PFLt), one modi?ed With double enhancer 
domains [Maiti and Shepherd 244, Biochem. Biophys. Res. 
Comm. 440 (1998); Maiti and Shepherd, US. Pat. No. , 
5,850,019. 
FIG. 3 shoWs expression analysis of TSP genes in differ 
ent transgenic plant lines. The RNA Dot Blot shoWs negative 
response to control and vector controls but varying levels of 
RNA in 8 different transgenic plant lines. The Northern Blot 
shoWs presence of TSP RNA in lanes 4, 5, and 8. Western 
Blot analysis contains TSP control in lane 1, control leaf 
extract in lane 2, control seedling extract in lane 3, trans 
formed leaf extract in lane 4 and transformed seedling 
extract in lane 5. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention provides materials and methods 
related to causing groWth inhibition and developmental 
arrest of Lepidoptera larvae. 
Speci?cally, the present invention provides nucleic acid 
compounds Which encode a teratocyte secreted protein 
(named TSP for the purposes of the present invention) Which 
is capable of causing inhibition of groWth and developmen 
tal arrest of Heliothis larvae. A nucleic acid compound 
speci?cally set forth in the sequence listing encodes one 
such teratocyte secreted protein from M. croceipes. The 
nucleic acid compounds include fragments and comple 
ments of the sequence in the sequence listing, as Well as 
sequences Which can be obtained, Without undue 
experimentation, by virtue of the knoWledge of these 
sequences. The nucleic acid compounds herein provided 
therefore include variations on the fragments, complements 
and other sequences, such as vectors or other constructs 
containing the fragments, complements, allelic variants and 
homologues. Cells and plants (including plant parts, seeds, 
embryos, etc.) comprising the nucleic acid compounds are 
also Within the scope of the present invention. 
The present invention also provides amino acid com 
pounds encoded by the nucleic acid compounds of the 
present invention, as Well as methods to induce larval 














and amino acid compounds, and methods to reduce crop 
damage due to a variety of Lepidopteran larval pests, 
including Heliothis and Helicoverpa species infestations. 
Therefore, the present invention provides isolated nucleic 
acid molecules encoding a TSP protein molecule, Wherein 
said nucleic acid molecule comprises a nucleic acid 
sequence selected from the group consisting of: 
(a) a nucleic acid molecule Which has more than 70% 
identity to a nucleic acid molecule selected from the 
group consisting of: SEQ ID NO 1 and SEQ ID NO 3, 
Wherein said identity can be determined using the 
DNAsis computer program and default parameters; 
(b) a nucleic acid molecule Which encodes an amino acid 
sequence Which comprises an amino acid sequence 
Which has more than 70% identity to an amino acid 
sequence selected from the group consisting of: SEQ 
ID NO 2 and SEQ ID NO 4, Wherein said identity can 
be determined using the DNAsis computer program 
and default parameters; 
(c) a nucleic acid molecule Which is an allelic variant of 
a nucleic acid molecule selected from the group con 
sisting of: a nucleic acid molecule of (a); and a nucleic 
acid molecule of (b); and 
(d) a nucleic acid molecule fully complementary to a 
nucleic acid molecule selected from the group consist 
ing of: a nucleic acid molecule of (a); a nucleic acid 
molecule of (b); and a nucleic acid molecule of 
Also provided are vectors, in particular vectors compris 
ing inducible promoters, and for those comprising inducible 
promoters, in particular those Which are tightly regulated. 
Recombinant plant cells, seeds, plant parts, embryos and 
plants comprising these vectors are also provided. Preferred 
are plants selected from the group consisting of tobacco, 
cotton, corn, soybeans, and tomatoes. 
It is Well-known in the art that there are commercially 
available computer programs for determining the degree of 
similarity betWeen tWo nucleic acid sequences. These com 
puter programs include various knoWn methods to determine 
the percentage identity and the number and length of gaps 
betWeen hybrid nucleic acid molecules. Preferred methods 
to determine the percent identity among amino acid 
sequences and also among nucleic acid sequences include 
analysis using one or more of the commercially available 
computer programs designed to compare and analyZe 
nucleic acid or amino acid sequences. These computer 
programs include, but are not limited to, GCG“ (available 
from Genetics Computer Group, Madison, Wis.), DNAsis“ 
(available from Hitachi SoftWare, San Bruno, Calif.) and 
MacVector“ (available from the Eastman Kodak Company, 
NeW Haven, Conn.). A preferred method to determine per 
cent identity among amino acid sequences and also among 
nucleic acid sequences includes using the Compare function 
by maximum matching Within the program DNAsis Version 
2.1 using default parameters. A nucleic acid sequence of the 
present invention may have at least 65%, preferably 70%, 
and most preferably 90% sequence identity With a nucleic 
acid molecule in the sequence listing. HoWever, any percent 
identity Within the range of 65 through 100% is Within the 
scope of the present invention. Therefore, molecules With 
80%, 85% and 95% identity are also Within the scope of the 
present invention. 
Therefore, also provided are isolated nucleic acid com 
pounds encoding a TSP protein molecule, Wherein said 
nucleic acid compound is selected from the group consisting 
of: 
(a) a nucleic acid molecule Which has more than 90% 
identity to a nucleic acid molecule selected from the 
US 6,337,432 B1 
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group consisting of: SEQ ID NO 1 and SEQ ID NO 3, 
wherein said identity can be determined using the 
DNAsis computer program and default parameters 
(b) a nucleic acid molecule Which encodes an amino acid 
sequence Which comprises an amino acid sequence 
Which has more than 90% identity to an amino acid 
sequence selected from the group consisting of: SEQ 
ID NO 2 and SEQ ID NO 4, Wherein said identity can 
be determined using the DNAsis computer program 
and default parameters; 
(c) a nucleic acid molecule Which is an allelic variant of 
a nucleic acid molecule selected from the group con 
sisting of: a nucleic acid molecule of (a); and a nucleic 
acid molecule of (b); and 
(d) a nucleic acid molecule fully complementary to a 
nucleic acid molecule selected from the group consist 
ing of: a nucleic acid molecule of (a); a nucleic acid 
molecule of (b); and a nucleic acid molecule of 
Also provided are vectors, in particular vectors compris 
ing inducible promoters, and for those comprising inducible 
promoters, in particular those Which are tightly regulated. 
Recombinant plant cells, seeds, plant parts, embryos and 
plants comprising these vectors are also provided. Preferred 
are plants selected from the group consisting of tobacco, 
cotton, corn, soybeans, and tomatoes. 
Also provided by the present invention are isolated 
nucleic acid compounds comprising a nucleic acid com 
pound Which hybridizes under stringent conditions to a 
nucleic acid molecule selected from the group consisting of: 
(a) SEQ ID NO 1 and SEQ ID NO 3. 
Stringent hybridization conditions are determined based 
on de?ned physical properties of the gene to Which the 
nucleic acid molecule is being hybridized, and can be 
de?ned mathematically. Stringent hybridization conditions 
are those experimental parameters that alloW an individual 
skilled in the art to identify signi?cant similarities -betWeen 
heterologous nucleic acid molecules. These conditions are 
Well knoWn to those skilled in the art. See, for example, 
Sambrook, et al., (1989), Molecular Cloning: A Laboratory 
Manual, Cold Spring Harbor Labs Press, and Meinkoth, et 
al., 138 Anal. Biochem. 267 (1984), each of Which is 
incorporated by reference herein in its entirety. As explained 
in detail in the cited references, the determination of hybrid 
ization conditions involves the manipulation of a set of 
variables including the ionic strength (M, in moles/liter), the 
hybridization temperature (° C.), the concentration of 
nucleic acid helix destabilizing agents (such as formainide), 
the average length of the shortest hybrid duplex (n), and the 
percent G+C composition of the fragment to Which an 
unknoWn nucleic acid molecule is being hybridized. For 
nucleic acid molecules of at least about 75 nucleotides or 
more, these variables are inserted into a standard mathemati 
cal formula to calculate the melting temperature, or Tm, of 
a given nucleic acid molecule. As de?ned in the formula 
beloW, Tm is the temperature at Which tWo complementary 
nucleic acid molecule strands Will disassociate, assuming 
100% complementarity betWeen the tWo strands: Tm=81.5° 
C.+16.6 log M+0.41(%G+C)—500/n—0.61(% formamide). 
For nucleic acid molecules smaller than about 50 
nucleotides, hybrid stability is de?ned by the dissociation 
temperature (Td), Which is de?ned as the temperature at 
Which 50% of the duplexes dissociate. For these smaller 
molecules, the stability at a standard ionic strength is de?ned 
by the folloWing equation: Td=4(G+C)+2(A+T). Atempera 
ture of 5° C. beloW Td is used to detect hybridization 
betWeen perfectly matched molecules. 
Hybridization reactions are often carried out by attaching 














such as a membrane, and then hybridizing With a labeled 
nucleic acid molecule, typically referred to as a probe, 
suspended in a hybridization solution. Examples of com 
mnon hybridization reaction techniques include, but are not 
limited to, the Well-knoWn Southern and northern blotting 
procedures. Typically, the actual hybridization reaction is 
done under non-stringent conditions, i.e., at a loWer tem 
perature and/or a higher salt concentration, and then high 
stringency is achieved by Washing the membrane in a 
solution With a higher temperature and/or loWer salt con 
centration in order to achieve the desired stringency. 
Also Well knoWn to those skilled in the art is hoW 
base-pair mismatch, i.e. differences betWeen tWo nucleic 
acid molecules being compared, including non 
complementarity of bases at a given location, and gaps due 
to insertion or deletion of one or more bases at a given 
location on either of the nucleic acid molecules being 
compared, Will affect Tm or Td for nucleic acid molecules 
of different sizes. For example, Tm decreases about 1° C. for 
each 1% of mismatched base-pairs for hybrids greater than 
about 75 bp, and Td decreases about 5° C. for each mis 
matched base-pair for hybrids beloW about 50 bp. Condi 
tions for hybrids betWeen about 50 and about 75 base-pairs 
can be determined empirically and Without undue experi 
mentation using standard laboratory procedures Well knoWn 
to those skilled in the art. These simple procedures alloW one 
skilled in the art to set the hybridization conditions (by 
altering, for example, the salt concentration, the formamide 
concentration or the temperature) so that only nucleic acid 
hybrids With less than a speci?ed % base-pair mismatch Will 
hybridize. Stringent hybridization conditions are commonly 
understood by those skilled in the art to be those experi 
mental conditions that Will alloW hybridization betWeen 
molecules having about 30% or less base-pair mismatch 
(i.e., about 70% or greater identity). Because one skilled in 
the art can easily determine Whether a given nucleic acid 
molecule to be tested is less than or greater than about 50 
nucleotides and can therefore choose the appropriate for 
mula for determining hybridization conditions, he or she can 
determine Whether the nucleic acid molecule Will hybridize 
With a given gene under stringent hybridization conditions 
and similarly Whether the nucleic acid molecule Will hybrid 
ized under conditions designed to alloW a desired amount of 
base pair mismatch. 
Apreferred isolated nucleic acid compound of the present 
invention is one Which comprises SEQ ID NO 3, With SEQ 
ID NO 1, or a fragment thereof being most preferred. SEQ 
ID NO 1 is a most preferred fragment of SEQ ID NO 3. 
HoWever, an isolated nucleic acid compound Which is an 
approximately 0.9 kb cDNA fragment isolated from 
Microplitis croceipes teratocytes, and Which fragment 
hybridizes to SEQ ID NO 1 or SEQ ID NO 3 under stringent 
conditions, is preferred. 
Included Within the scope of the present invention, With 
particular regard to the nucleic acids above, are allelic 
variants, degenerate sequences and homologues. Allelic 
variants are Well knoWn to those skilled in the art and Would 
be expected to be found Within a given insect, plant or 
microbe and/or among a group of tWo or more insects, plants 
or microbes. The present invention also includes variants of 
TSP due to laboratory manipulation, such as, but not limited 
to, variants produced during polymerase chain reaction 
ampli?cation or site directed mutagenesis. It is also Well 
knoWn that there is a substantial amount of redundancy in 
the various codons Which code for speci?c amino acids. 
Moreover, variants of the universal code, such as are present 
in some plant, animal and fungal mitochondria, the bacte 
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rium Mycoplasma capricolum [Yamo et al., 82 Proc. Natl. 
Acad. Sci. (USA) 2306 (1985)] or the ciliate Macronucleus, 
may be used When the nucleic acid is expressed using these 
organisms. Therefore, this invention is also directed to those 
nucleic acid sequences Which contain alternative codons 
Which code for the eventual translation of the amino acid. 
Methods to mutate genes are Well-knoWn to those in the art. 
Several books, including text books and laboratory manuals 
are available on the subject. For instance, Sambrook et al., 
Molecular Cloning. A Laboratory Manual (Cold Spring 
Harbor Laboratory Press, 1989); Ausubel et al., Current 
Protocols in Molecular Biology (Greene Publishing 
Associates, Inc., 1993) are typical. Moreover, commercial 
ventures sell kits that have instructions and materials that 
even those With less than ordinary skill could folloW. Kits 
can be obtained from http://WWW.sciquest.com, (800) 233 
1211. 
Also included Within the scope of this invention are 
mutations either in the nucleic acid sequence or the trans 
lated protein Which do not substantially alter the ultimate 
physical properties of the expressed protein. For example, 
substitution of valine for leucine, arginine for lysine, or 
asparagine for glutamine may not cause a change in func 
tionality of the polypeptide. Lastly, a nucleic acid sequence 
homologous to the exempli?ed nucleic acid compounds (or 
allelic variants or degenerates thereof) Will have at least 
70%, preferably 80%, and most preferably 90% sequence 
homology With the nucleic acid compounds in the sequence 
listing. Most preferred is a mRNA Which is complementary 
to the DNA compounds in the sequence listing. In other 
Words, a mRNA nucleic acid sequence homologous to a 
DNA nucleic acid sequence is characteriZed by the ability to 
hybridiZe to the exempli?ed nucleic acid compounds (or 
allelic variants or degenerates thereof) under stringent con 
ditions. Stringent hybridiZation conditions, and alterations 
of amino acids in a polypeptide are Well knoWn, and are 
described, for example, in Sambrook et al., Molecular 
Cloning. A Laboratory Manual (Cold Spring Harbor Labo 
ratory Press, 1989). 
A variety of procedures knoWn in the art may be used to 
molecularly clone the present nucleic acids. These methods 
include, but are not limited to, complementation for function 
folloWing the construction of a genomic DNA library in an 
appropriate vector system. Another method is to screen a 
genoric DNA library constructed in a bacteriophage or 
plasmid shuttle vector With a labeled oligonucleotide probe 
designed from the amino acid sequence of the gene. An 
additional method consists of screening genomic DNA 
libraries constructed in a bacteriophage or plasmid shuttle 
vector With a partial DNA encoding the gene. This partial 
DNA is obtained by speci?c PCR ampli?cation of the gene 
DNA fragments through the design of degenerate oligo 
nucleotide primers from the amino acid sequence of the 
puri?ed gene product or by using another member of the 
gene family as a probe. Sambrook et al., Molecular Cloning. 
A Laboratory Manual (Cold Spring Harbor Laboratory 
Press, 1989) and Ausubel et al., Current Protocols in 
Molecular Biology (Greene Publishing Associates, Inc., 
1993) describe these procedures. Alternatively, the nucleic 
acids can be prepared as exempli?ed herein. 
When the nucleic acid is prepared or altered synthetically, 
advantage can be taken of knoWn codon preferences of the 
intended host Where the nucleic acid is to be expressed. For 
example, although nucleic acid sequences of the present 
invention may be expressed in both monocotyledonous and 
dicotyledonous plant species, sequences can be modi?ed to 














preferences of monocotyledons or dicotyledons as these 
preferences have been shoWn to differ. Murray et al., 17 
Nucl. Acids Res. 477 (1989). Thus, the maiZe preferred 
codon for a particular amino acid may be derived from 
knoWn gene sequences from maiZe. MaiZe codon usage for 
28 genes from maiZe plants are listed in Table 4 of Murray 
et al., supra. 
The cloned nucleic acids may be expressed through the 
methods described in the examples or methods knoWn in the 
art. The DNA can be recombinantly expressed by molecular 
cloning into an expression vector containing a suitable 
promoter and other appropriate transcription regulatory 
elements, and transferred into prokaryotic or eukaryotic host 
cells to produce recombinant gene product. Techniques for 
such manipulations are fully described in Sambrook, et al., 
supra. Expression vectors can be used to express genes in a 
variety of hosts such as bacteria, bluegreen algae, plant cells, 
insect cells, fungal cells and animal cells. Expression vectors 
may include, but are not limited to, cloning vectors, modi 
?ed cloning vectors, speci?cally designed plasmids or 
viruses. 
Vectors Which comprise the nucleic acid compounds are 
Within the scope of the present invention, as are plants 
transformed With the above nucleic acid compounds. Vec 
tors may be obtained from various commercial sources, 
including Clontech Laboratories, Inc. (Palo Alto, Calif.), 
Stratagene (La Jolla, Calif.), Invitrogen (Carlsbad, Calif.), 
NeW England Biolabs (Beverly, Mass.) and Promega 
(Madison, Wis.). 
Preferred vectors are those Which are capable of transfer 
ring the sequences disclosed herein into plant cells or plant 
parts. Expression vectors are preferred, With expression 
vectors comprising an inducible promoter operably linked to 
the nucleic acid compound being more preferred. “Induc 
ible” promoters typically direct expression of a polynucle 
otide in a speci?c tissue or may be otherWise under more 
precise environmental or developmental control. The most 
preferred vectors herein provided are expression vectors 
comprising a tightly-regulated inducible promoter operably 
linked to the nucleic acid compound. 
Environmental conditions that may effect transcription by 
inducible promoters include pathogen attack, anaerobic con 
ditions or the presence of light. Examples of inducible 
promoters are the Adhl promoter Which is inducible by 
hypoxia or cold stress, the Hsp70 promoter Which is induc 
ible by heat stress, and the PPDK promoter Which is 
inducible by light. Examples of promoters under develop 
mental control include promoters that initiate transcription 
only, or preferentially, in certain tissues, such as leaves, 
roots, fruit, seeds or ?oWers. An exemplary promoter is the 
anther speci?c promoter 5126 (US. Pat. Nos. 5,689,049 and 
5,689,051). The operation of a promoter may also vary 
depending on its location in the genome. Thus, an inducible 
promoter may become fully or partially constitutive in 
certain locations. 
A number of promoters can be used in the practice of the 
invention. The promoters can be selected based on the 
desired outcome. For the purposes of the present invention, 
a Wound-inducible promoter may be used in the construc 
tions of the invention. Such Wound inducible promoters 
include potato proteinase inhibitor (pin 11) gene (Ryan, 28 
Annu. Rev. Phytopath. 425 (1990); Duan et al., 14 Nature 
Biotech. 494 (1996); Wun1 and Wun2, US. Pat. Ser. No. 
5,428,148; Win1 and Win2 (Stanford et al., 215 Mol. Gen. 
Genet. 200 (1989); systemin (McGurl et al., 225 Science 
1570 (1992); WIPI (Rohmeier et al., 22 Plant Mol. Biol. 783 
(1993); Eckelkamp et al., 323 FEBS Let. 73 (1993); MP1 
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gene (Corderok et al., 6 Plant J. 141 (1994) and references 
contained therein. This invention is appropriate for use in all 
crops potentially attacked by lepidopteran pests. These crops 
include cotton, maize, soybean, tomato and tobacco. 
Promoters as described in the previous paragraphs are 
also preferred for use in the present vectors. Chemically 
inducible promoters, such as PR-2b and PR-2d genes Which 
are induced by salicylic acid, can either be constructed de 
novo according to knoWn techniques, or obtained from 
various commercial sources, including those described 
above ,for obtaining vectors. Construction of vectors com 
prising promoters in frame With nucleic -acids is knoWn in 
the art, and can be accomplished according to Sambrook et 
al., Molecular Cloning. A Laboratory Manual (Cold Spring 
Harbor Laboratory Press, 1989) and Ausubel et al., Current 
Protocols in Molecular Biology (Greene Publishing 
Associates, Inc., 1993). A general method for the construc 
tion of any desired DNA sequence is provided in BroWn et 
al., [68 Methods in Enzymology 109 (1979)]. Also provided 
are vectors comprising rice actin and rice ubiquitin consti 
tutive promoters and the nucleic acid compounds herein. In 
addition, there are other plant viral promoters Which may be 
used to express genes of the present invention. 
Also included in the present invention are recombinant 
plant cells, recombinant seeds, recombinant plant embryos 
and recombinant plants comprising the vectors described 
herein. Seeds, embryos, plants or plant parts Which recom 
binantly express the present amino acid compound(s) or 
comprise herein-disclosed constructs are preferred embodi 
ments of the present invention. Of course, those in the art 
recogniZe that any seed, embryo or plant transformed With 
the present constructs Which are useful for producing plants 
for biomass are Within the scope of the present invention. 
Therefore, the present invention includes seeds, embryos, 
plants or plant parts Which recombinantly express an iso 
lated nucleic acid compound, Wherein said nucleic acid 
compound encodes an amino acid compound selected from 
the group consisting of: SEQ ID NO 4; a fragment of SEQ 
ID NO 4; an amino acid compound encoded by an allelic 
variant of a nucleic acid compound encoding SEQ ID NO 4; 
and a fragment of an amino acid compound encoded by an 
allelic variant of a nucleic acid compound encoding SEQ ID 
NO 4. The present invention also provides seeds, embryos, 
plants or plant parts Which recombinantly express isolated 
nucleic acid compounds comprising a nucleic acid com 
pound Which hybridiZes under stringent conditions to SEQ 
ID NO 3. 
For example, the folloWing seeds, embryos, plants or 
plant parts transformed With herein-disclosed nucleic acid 
constructs are considered Within the present invention: rice; 
soybean; cotton; maiZe; beet; tobacco; Wheat; barley; poppy; 
rape; sun?oWer; alfalfa; sorghum; rose; carnation; gerbera; 
carrot; tomato; egg plant; lettuce; chicory; pepper; melon; 
cabbage; canola; banana; papaya; casava; fruit and nut trees; 
tulip; orchid and lilly. Particularly preferred are: tobacco, 
cotton, maiZe, soybeans and tomatoes. 
Transformation of cells With the nucleic acid compounds 
of the present invention can be accomplished according to 
knoWn procedures. For example, infective, vector 
containing bacterial strains (such as Agrobacterium rhizo 
genes and Agrobacterium tumefaciens) may be used for 
transformation. Zambryski, 43 Ann. Rev. Pl. PhysioL Pl. 
Mol. Biol. 465 (1992). The folloWing procedures are also 
Well-known: Pollen-tube transformation [Zhon-xun et al., 6 
Plant Molec. Bio. 165 (1988)]; direct transformation of 
germinating seeds [Toepfer et al., 1 Plant Cell 133 (1989)]; 














[Christou et al., 84 Proc. Nat. Acad. Sci. 3662 (1987)]; and 
biolistic processes [Yang & Cristou, Particle Bombardment 
Technology for Gene Transfer (1994)]. The transformed 
cells are also Within the scope of the present invention. 
The transformed cells may be induced to form trans 
formed plants via organogenesis or embryogenesis, accord 
ing to the procedures of Dixon Plant Cell Culture: A 
PracticalApproach (IRL Press, Oxford 1987). 
In another aspect of the present invention, there is pro 
vided isolated TSP protein molecules, Wherein said TSP 
protein molecule comprises an amino acid sequence selected 
from the group consisting of: 
(a) an amino acid sequence encoded by a nucleic acid 
molecule Which has more than 70% identity to a 
nucleic acid molecule selected from the group consist 
ing of: SEQ ID NO 1 and SEQ ID NO 3, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters; and 
(b) an amino acid sequence Which comprises an amino 
acid sequence Which has more than 70% identity to an 
amino acid sequence selected from the group consisting 
of: SEQ ID NO 2 and SEQ ID NO 4, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters. 
Recombinant plant cells and plants comprising the dis 
closed proteins are also provided. Preferred are those recom 
binant plants selected from the group consisting of tobacco, 
cotton, corn, soybeans, and tomatoes. 
Isolated TSP protein molecules With 65% to 100% 
sequence identity to the sequence listing compounds are 
provided. Indeed, those Which are 75%, 80%, 85%, and 95% 
identical are speci?cally pointed out as part of the present 
invention. Moreover, also provided are those isolated TSP 
protein molecules, Wherein said TSP protein molecule com 
prises an amino acid sequence selected from the group 
consisting of: 
(a) an amino acid sequence encoded by a nucleic acid 
molecule Which has more than 90% identity to a 
nucleic acid molecule selected from the group consist 
ing of: SEQ ID NO 1 and SEQ ID NO 3, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters; and 
(b) an amino acid sequence Which comprises an amino 
acid sequence Which has more than 90% identity to an 
amino acid sequence selected from the group consisting 
of: SEQ ID NO 2 and SEQ ID NO 4, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters. 
Recombinant plant cells and plants comprising the dis 
closed proteins are also provided. Preferred are those recom 
binant plants selected from the group consisting of tobacco, 
cotton, corn, soybeans, and tomatoes. 
Most preferred is an isolated amino acid compound Which 
is SEQ ID NO 2, although any portion of SEQ ID NO 2 
Which has the ability to cause impaired groWth and devel 
opment in lepidoptera larvae is considered part of the 
present invention as Well. Modi?cations of the amino acid 
compounds, such as conservative changes in the amino acid 
sequence, removal of proteolytic cleavage sites to stabilize 
the peptide, or modi?cations useful to identify existence or 
location of gene products are also Within the scope of the 
present invention. For example, an engineered antibody 
recognition site Would be helpful for research purposes, or 
for quality-control in a commercial plant. Such modi?ca 
tions can be accomplished according to Young et al., [9 Mol. 
Plant-Microb. Interact. 105 (1994)]. 
The amino acid compounds of the present invention can 
be puri?ed according to common puri?cation techniques, 
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such as that described in Bollag et a1., Protein Methods 
(Wiley-Liss 1996); Scopes, Protein Puri?cation: Principles 
and Practice (Springer-Verlag 1994); Doonan, Protein Puri 
?cation Protocols (Humana Press 1996). For example, arti 
sans Will also recognize that these compounds (or portions 
thereof) can be synthesized by Well-known solid phase 
peptide synthesis or recombinant DNA methods. 
For puri?cation via recombinant DNA methods, follow 
ing expression of the nucleic acids disclosed above in a 
recombinant host cell, the amino acid compounds described 
herein can be recovered in puri?ed form. Several puri?ca 
tion procedures are available and suitable for use. For 
example, the amino acid compounds may be puri?ed from 
cell lysates and extracts by various combinations of, or 
individual application of salt fractionation, ion exchange 
chromatography, siZe exclusion chromatography, hydroxya 
patite adsorption chromatography and hydrophobic interac 
tion chromatography. In addition, the amino acid compound 
can be separated from other cellular proteins by use of an 
immunoaffinity column made With monoclonal or poly 
clonal antibodies speci?c for the full length nascent gene 
product, or polypeptide fragments of the gene product. 
Finally, if the vector is modi?ed to include a poly-histidine 
tag, the expressed protein can be puri?ed by nickel affinity 
chromatography. 
Also provided are methods to construct an insect resistant 
plant, comprising: introducing into a plurality of plant cells 
an isolated nucleic acid compound selected from the group 
consisting of: 
(a) a nucleic acid molecule Which has more than 70% 
identity to a nucleic acid molecule selected from the 
group consisting of: SEQ ID NO 1 and SEQ ID NO 3, 
Wherein said identity can be determined using the 
DNAsis computer program and default parameters 
(b) a nucleic acid molecule Which encodes an amino acid 
sequence Which comprises an amino acid sequence 
Which has more than 70% identity to an amino acid 
sequence selected from the group consisting of: SEQ 
ID NO 2 and SEQ ID NO 4, Wherein said identity can 
be determined using the DNAsis computer program 
and default parameters; and 
(c) a nucleic acid molecule Which is an allelic variant of 
a nucleic acid molecule selected from the group con 
sisting of: a nucleic acid molecule of (a); and a nucleic 
acid molecule of (b); and causing at least some of the 
plant cells to groW into at least one plant; and selecting 
those plants Which contain the nucleic acid introduced. 
Therefore, also provided are formulations for topical 
pesticides comprising the amino acid compounds herein 
disclosed. For instance TSP (SEQ ID NO 2) can be used as 
an ingredient, or alone, in a mixture, suspension, etc. for 
application directly to Heliothis-infested or potentially 
infested plants. Alternatively, the TSP gene (either SEQ ID 
1 or SEQ ID 3 or modi?cations thereof) might be used With 
a recombinant baculovirus insecticide Whereby the bacu 
lovirus infects the insect and as the virus reproduces it over 
expresses the TSP gene. Bonning and Hammock, 41 Ann. 
Rev. Entomol. 191 (1996). 
In particular, there are provided methods to confer insect 
resistance properties to a plant, comprising applying to the 
surface of a plant an isolated nucleic acid molecule selected 
from the group consisting of: 
(a) a nucleic acid molecule Which has more than 70% 
identity to a nucleic acid molecule selected from the 
group consisting of: SEQ ID NO 1 and SEQ ID NO 3, 
Wherein said identity can be determined using the 







(b) a nucleic acid molecule Which encodes an amino acid 
sequence Which comprises an amino acid sequence 
Which has more than 70% identity to an amino acid 
sequence selected from the group consisting of: SEQ 
ID NO 2 and SEQ ID NO 4, Wherein said identity can 
be determined using the DNAsis computer program 
and default parameters; and 
(c) a nucleic acid molecule Which is an allelic variant of 
a nucleic acid molecule selected from the group con 
sisting of: a nucleic acid molecule of (a); and a nucleic 
acid molecule of 
Also in particular, there are provided methods to confer 
insect resistance properties to a plant, comprising applying 
to the surface of a plant an isolated amino acid molecule 
selected from the group consisting of: 
(a) an amino acid sequence encoded by a nucleic acid 
molecule Which has more than 70% identity to a 
nucleic acid molecule selected from the group consist 
ing of: SEQ ID NO 1 and SEQ ID NO 3, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters; and 
(b) an amino acid sequence Which comprises an amino 
acid sequence Which has more than 70% identity to an 
amino acid sequence selected from the group consisting 
of: SEQ ID NO 2 and SEQ ID NO 4, Wherein said 
identity can be determined using the DNAsis computer 
program and default parameters. 
Moreover, there are provided methods to confer consti 
tutive and/or inducible Lepidoptera resistance to a plant, 
comprising transforming the plant With a vector comprising 
the nucleic acid sequences described herein. Since Lepi 
doptera resistance is one characteristic conferred to a plant 
by the TSP genes disclosed herein, an ideal method Would 
be to activate the sequences disclosed herein for the amount 
of time and in quantities necessary to ?ght the pest, and no 
longer, since the genes utiliZe energy that could otherWise be 
used to create biomass and/or fruit development. 
In particular, there are provided methods to confer Lepi 
doptera resistance in a plant, comprising: transforming at 
least one plant With a inducible promoter-comprising vector 
of the present invention, and introducing to the plant an 
inducing agent capable of inducing the inducible promoter 
of the vector, and providing the time and conditions needed 
to cause inducement. 
Also provided are methods to induce a Lepidoptera resis 
tance response in a plant transformed With the nucleic acids 
described herein, comprising: introducing to the plant an 
agent or environmental conditions capable of inducing the 
inducible promoter of the vector, and providing the time and 
conditions needed to cause inducement, and causing induce 
ment. Preferred agents are pathogens, and preferred envi 
ronmental conditions are Wounds. HoWever, it is also Within 
the scope of the present invention to select a plant part into 
Which a vector is transformed, and selectively cause Lepi 
doptera resistance in response to a developmental stage of 
the plant, such as upon ?oWering or at a particular fruit 
developmental stage. For instance, Heliothis larvae prefer 
feeding in the groWing bud and developing fruit. Resistance 
could be engineered to coincide With these groWing tissues. 
Transformation of plants With these sequences Would be 
according to Well-known procedures as described above. 
Plants can be groWn according to Well-known procedures. 
EXAMPLES 
Example 1—Insect Populations 
Heliothis virescens larvae Were reared on arti?cial diet in 
a continuous colony maintained at the 2512° C. With a 16:8 
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(L:D) photoperiod at the University of Kentucky as 
described by VanderZant [55 J. Econ. Entomol. 140 (1962)]. 
Prospective host Heliothis larvae Were removed from the 
colony as pharate fourth instars and parasitiZed for both 
colony maintenance and subsequent collection of parasite 
eggs. ParasitiZation Was accomplished by exposing host 
larvae for approximately 1 h to mated female M. croceipes 
Wasps at a ratio of 8:1. ParasitiZed larvae Were placed into 
individual cups containing diet and held at 27:2° C. After 
emergence, the adult parasite Wasps Were kept at an approxi 
mate 1:1 sex ratio and supplied With honey:Water (1:1). 
Zhang et al., 20 Arch. Insect Biochem. Physiol. 231 (1992). 
Example 2—General Procedures 
The in vitro culturing of teratocytes and subsequent 
collection of the proteins secreted by the teratocytes Were 
described by Schepers et al. [44 J. Insect Physiol. 767 
(1998)]. Host H. verescens larvae Were superparasitiZed by 
placing 10 larvae and an equal number of Wasps in a 15x15 
cm plastic petri dish Which Was placed in a lighted incubator 
at 27° C. for 2 h. Individual superparasitiZed larvae Were 
placed in 18 mL plastic cups containing diet and held at 27° 
C. for 28 h. M. croceipes eggs Were obtained by sterile 
dissection of superparasitiZed H. verescens larvae 28 h after 
parasitiZation. FolloWing surface steriliZation by emersion in 
95% and 70% ethanol, the larvae Were held in sterile Water 
until used for dissection. A larva Was placed in a Well of a 
depression slide along With 100 uL of Ex-cell 400 medium 
(JHR Biosciences, Lexana, Kans.) With 60 ug/mL of gen 
tamicin sulfate. TWo ?ne forceps Were used to open the 
integument Without breaking the midgut. The exposed mid 
gut Was dipped into the medium and the integument Was 
massaged With forceps to force the M. croceipes eggs into 
the medium. Eggs Were collected With a capillary micropi 
pette and Washed ?ve times by transfer to fresh sterile 100 
uL drops of Ex-cell 400. Ten Washed eggs Were placed in 
each of three 100 ML drops of Ex-Cell 400 placed in a 5x09 
cm tightly sealed Petri dish. The dishes Were held in an 
incubator at 27° C. The eggs hatch approximately 14 h after 
dissection With each egg yielding approximately 900 tera 
tocytes. Zhang et al. 23 Int. J. Insect Morphol. & Embryol. 
173 (1994). The teratocytes dissociate from the chorion and 
begin secreting proteins (TSP). For TSP collection the 
teratocytes, parasite larvae and medium Were placed into 
microcentrifuge tubes, the parasite larvae Were alloWed to 
settle, then the medium and teratocytes Were removed With 
a pipette to a separate microcentrifuge tube Which Was 
centrifuged for 5 min at 800><g. The supernatant contained 
the crude TSP. One larval equivalent (LE) of TSP is that 
amount (~2 ug of protein) secreted by an in vitro culture of 
teratocytes derived from a larva during a period of three 
days. In some cases, the fraction of TSP that passes through 
a 30 kD molecular Weight ?lter but is retained by a 3 kD 
?lter Was used for assays (Schepers et al. supra). The 
dye-binding Bio-Rad protein reagent (Bio-Rad 
Laboratories, Hercules, Calif.) Was used to determine pro 
tein concentrations using bovine serum albumen as a stan 
dard assay [Bradford, 72 Anal. Biochem. 248 (1976)]. Cen 
tricon (Amicon, Inc., Beverly, Mass.) molecular Weight 
cutoff ?lters Were used folloWing the manufacture’s direc 
tions. SDS-PAGE Was performed using a standard method 
[Laemelli, 227 Nature 680 (1970)] and visualiZed With 
Coomassie blue and/or silver stain. Southern and northern 
blots folloWed standard procedures [Sambrook et al., 
Molecular Cloning. A Laboratory Manual, Cold Spring 
Harbor Laboratory Press (1989); Ausubel et al., Current 














Associates, Inc., (1993)]. Reversed phase HPLC using a 
2.1><250 mm VyDac C18 column, 5n, 300Apacking material 
Was used to separate protein components in the 3—30 kD 
fraction and to separate peptide fractions after hydrolysis of 
the isolated 13.9 kD protein. The How rate Was 150 uL/min 
With a binary gradient changing the percentages of 0.06% 
TFA versus 0.054% TFA in 70% acetonitrile over a 2 h 
period. Each HPLC peak Was collected, concentrated, and 
subjected to SDS-PAGE. 
Example 3—Expression of the 14 kD cDNA 
The 13.9 kD protein Was puri?ed from approximately 
1500 LE of TSP obtained from teratocytes cultured in vitro. 
Details related to the use of speci?c procedures cited in this 
example are described Example 2—General Procedures. 
The protein of interest passed through a 30 kD molecular 
Weight ?lter but Was retained by a 3 kD ?lter. Schepers et al., 
44 J. Insect Physiol. 767 (1998). The 13.9 kD protein Was 
separated from the other 3 TSP proteins in the biologically 
active fraction by reversed phase HPLC. The most abundant 
protein (13.9 kD) Was selected for the initial analysis. It Was 
digested With the Lys-C protease and rechromatographed on 
a C 18 column. TWo of the fragments Were selected for 
amino acid sequencing using an Applied Biosystems 477A 
Protein Sequencer. One fragment provided a sequence of 
only 5 amino acids (VTWYN) While the other fragment Was 
sequenced through 28 positions 
(PFDFSDDGNOSCAPASGICHRVGLEITK). 
To select a cDNA encoding TSP, 2 degenerate primers 
Were synthesiZed taking advantage of inferred lysine resi 
dues N-terminal to the derived peptide sequence (inferred 
because of Lys-C digestion); terat 1 (SEQ ID NO 
5)=AARGTNACNTGGTAYAA; and terat 2 (SEQ ID NO 
6)=AARCAYCCNTTYGAYTT. The 3‘ end and subse 
quently the 5‘ end of the cDNA Was isolated using the PCR 
based approach of rapid ampli?cation of cDNA ends 
[RACE, Frohman IN: Innis PC et al., PCR Protocols, 
Academic Press 28 (1990); Clackson et al. IN: McPherson 
et al., PCR: A PracticalApproach, IRL Press, 187, (1991)]. 
Brie?y, an oligo-dT primer (ODT) Was used to synthesiZe 
cDNA from 1 ug of teratocyte RNA. The degenerate oligo 
nucleotide primers, terat 1 and terat 2, Were used in parallel 
reactions to prime second strand cDNA synthesis then 
ampli?ed in a conventional PCR reaction (terat 1+ODT and 
terat 2+ODT). The terat 1+ODT reaction produced a single 
major amplimer of about 150 bp While the terat 2+ODT 
reaction produced a major product of approximately 540 bp. 
The 540 bp amplimer Was cloned and sequenced. The signal 
peptide and untranslated leader sequence Were obtained 
from a 5‘ RACE product. The composite sequence encodes 
all 33 amino acids knoWn from peptide sequence data and 
shoWs that the terat 2 peptide sequence is N-terminal to the 
terat 1 peptide, as suggested by the initial ampli?cation 
products. The complete cDNA contains an open reading 
frame of 426 nucleotides that encodes a 23 amino acid signal 
peptide and a total of 129 amino acids With a predicted 
molecular Weight of 14,012. After the removal of the signal 
peptide, the predicted Weight of the secreted protein is 
11,466, relatively close to the 13.9 kD molecular Weight of 
the most abundant protein in the 3—30 kD fraction, as 
estimated by SDS-PAGE. The “inferred” lysine residue used 
in construction of the terat 2 oligonucleotide Was not present 
in the predicted peptide sequence because this peptide 
sequence Was from the N-terminus of the mature protein. A 
17 bp primer-speci?ed poly A tail Was preceded by tWo 
consensus poly-adenylation signals. 
Inspection of the predicted amino acid sequence from the 
cDNA encoding the 14 kD TSP revealed a cysteine-motif 
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similar to those previously described from a polydnavirus 
(PDV). Alignment of the TSP-cysteine motif With the 6 
motifs from Campoletis sonorensis PDV shoWs that all 6 
cysteine residues Were conserved at similar spacing to those 
observed in CsPDVs. A 4 amino acid core (KPCC) Was also 
present in the TSP motif. 
The cDNA encoding TSP Was expressed only from 
teratocytes, Was encoded by the Wasp genome, apparently as 
a single copy gene, and did not hybridiZe to the M. croceipes 
PDV genome (T. Schepers and Webb, unpublished). To 
localiZe the TSP gene, DNA Was extracted from adult male 
M. croceipes Wasps and from viral DNA. TWo micrograms 
of viral DNA and 10 pg of male Wasp genomic DNA Was 
blotted to nylon membrane in a dot blot apparatus. Cloned 
TSP Was used as a positive control With pZero vector DNA 
used as a negative control (5 pig each). Only the Wasp 
genomic and positive control DNAs hybridiZed to the TSP 
probe. Viral and male Wasp genomic DNA Were then 
digested With BamH1 and Xba1 and hybridiZed under high 
stringency conditions (50% formamide, 5><SSC, 
5 ><Denhardt’s 20 mM Na phosphate With 100 pig/mL sheared 
salmon sperm DNA at 42° C.) to the TSP probe after 
electrophoresis on a 0.7% agarose gel and transfer to nylon 
membrane. TWo TSP hybridiZing bands Were visible on the 
genomic Southern blot suggesting that the TSP gene exists 
as a single copy gene in M. croceipes chromosomal DNA. 
The 14 kD cDNA Was expressed as a fusion to a poly 
histidine tag that simpli?es protein puri?cation in both 
prokaryotic (pET vectors, Novagen) and eukaryotic systems 
(baculovirus expression system) (BaculoGold, 
PharMingen). Webb and Summers, 87 Proc. Nat’lAcaa'. Sci. 
4961 (1990). An appropriate portion of the amino acid 
sequence of TSP Was synthesized and linked to keyhole 
lympet hemocyanin and used for antibody preparation. 
Southern blots. The TSP cDNA Was used to probe DNA 
prepared from the Wasp teratocytes and from M. croceipes 
polydnavirus (McPDV). The TSP cDNA bound exclusively 
to DNA from the Wasp teratocytes. 
Molecular analysis of the TSP cDNA. The protein 
expressed from the baculovirus system Was puri?ed for 
functional analyses. Three different preparations of recom 
binant TSP Were prepared and assessed With the testes assay. 
A0.5 pig/100 ML dose of TSP resulted in a 27.1:2.2% (n=11) 
reduction in protein synthesis by testes. Based on this 
information and the assumed molecular Weight of 11,466, 
the concentration Would be approximately 0.436 pmolar. 
Three LE of crude TSP used in a parallel set of experiments 
conducted at the same time yielded a 31.0:6.0% (n=9) 
reduction in protein synthesis. The control testis of each pair 
received an equivalent volume of buffer that Was identical to 
that obtained from the TSP preparation. 
Example 4—Immunological Analyses 
To produce a TSP antiserum, a peptide region of the TSP 
predicted to have a high degree of antigenicity Was synthe 
siZed according to the methods described in HarloW and 
Lane, Antibodies: A Laboratory Manual, Cold Spring Har 
bor Laboratory (1988) and linked to keyhole lympet 
hemocyanin. Polyclonal antibodies Were raised folloWing 
immuniZation procedures described by Huebers et al. [158 J. 
Comp. Physiol. B 291 (1988)]. The synthesiZed peptide Was 
injected into rabbits With an adjuvant. Four Weeks after the 
initial immuniZation the rabbits Were boosted With a similar 
amount of protein. TWo Weeks after the primary boost, the 
antiserum Was collected and evaluated With Western blots 














insects. Boost immuniZations Were performed until an anti 
serum With suitable speci?city and titer Was produced. 
Antiserum binding, speci?city and reactivity Were analyZed 
by transferring proteins from 16.5% SDS-PAGE gels to 
Immobilion-P (Milipore; Bedford, Mass.) membranes fol 
loWing the procedure of Li and Webb [68 J. Wrol. 7482 
(1994)] With alkaline phosphatase-conjugated anti-rabbit 
immunoglobulin G and 4-bromo-4-chloro-3 
indolylphosphate p-toluidine salt and nitroblue tetraZolium 
chloride as chromogenic substrates. In some trials, in order 
to achieve greater sensitivity, enhanced chemiluminescence 
With horseradish peroxidase and luminol substrate Was used 
folloWing the instructions provided With the kit (Pierce 
Chemical Co., Rockford, Ill.). 
An immune response Was evident to the bacterial TSP, but 
no protein Was detected in either the TSP fractions or in 
puri?ed TSP from the recombinant virus. HoWever, the 
antiserum obtained from a rabbit injected With a synthesiZed 
region of TSP and linked to keyhole lympet hemocyanin 
reacted to the protein that has been identi?ed as the secreted 
TSP. The antiserum Will be used for a variety of studies 
including the localiZation and function of TSP in host larval 
tissues and localiZation of TSP in transgenic plants. 
Example 5—Testis Assay 
Pairs of testes removed from digging Day 2 (D2) 5th 
stadium H. verescens Were processed in a manner similar to 
the fat body organ culture described by Schepers et al. [44 
J. Insect Physiol. 767 (1998)]. A single testis of the pair Was 
placed in a total volume of either 50 or 100 ML of methionine 
depleted medium and a volume of test material. Protein 
synthesis Was measured by [35S]-methionine incorporation 
during a 4 h incubation. The ratio of cpm from one of the 
testes pair incubated With the treatment (TSP or candidate 
fraction) and the other one of the testes pair (control) Was 
used to measure reduction in protein synthesis. 
In an assay that used 3 LE of crude TSP/50 nL of medium, 
We found a signi?cant decrease (82.8:5.4%) in the incor 
poration of [35S]-methionine in the treated testes compared 
to the controls (n=25). Schepers et al. supra reported that a 
signi?cant amount of the activity associated With reduction 
in protein synthesis in fat body organ assays Was con?ned to 
the fraction of TSP that passed through a 30 kD ?lter but Was 
retained by a 3 kD ?lter. When this fraction Was assessed 
using a rabbit reticulocyte lysate assay With mRNA from H. 
verescens testes, a dose of 3.5 LE/50 ML caused a 51311.4 
% decrease in the incorporation of [35S]-methionine (n=3). 
Although the percentage reduction Was less With the con 
centrated fraction of TSP, it is likely that not all the active 
component Was retained With the fraction, some being lost 
during the puri?cation process. 
Example 6—In Vitro Translation Assays 
The effect of TSP on mRNA translation Was assessed 
using a rabbit reticulocyte translation system (Life 
Technologies, Gaithersburg, Md.). One pig of mRNA Was 
used in a total volume of 25 nL. TSP and buffer controls 
Were concentrated With 3 kD Amicon ?lters prior to addition 
to the assay mixture. A Wheat germ extract translation 
system (Promega, Madison, Wis.) also Was used to assess 
the activity of 0.5 pg of TSP in a plant-derived system. 
When the recombinant TSP Was tested With a rabbit 
reticulocyte lysate assay an inverse dose-dependent effect 
Was observed over a range of 0.2—0.8 pig protein/25nL (FIG. 
1). The concentration of TSP at the highest dose Would be 
approximately 2.79 pmolar. 
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The Wheat germ assay is similar to the rabbit reticulocyte 
translation system except that Wheat germ tissue is used as 
a source of enzymes, cofactors, etc. It Was used to evaluate 
the effect of TSP mRNA translation in a cell-free system 
using plant-derived components. In a single experiment With 
six replications 0.5 pg of TSP signi?cantly reduced [35S] 
methionine uptake by 25%. 
Example 7—In Vivo Developmental Impairment 
Qualitative and quantitative changes in hemolymph pro 
teins in H. verescens Were observed in larvae injected With 
either M. croceipes teratocytes or crude TSP. Hemolymph 
protein titers in hosts receiving either 0.5 or 1 LE of 
teratoctyes Were similar to those of parasitiZed larvae, 
Whereas a single injection of 4 LE of crude TSP Was required 
to induce a similar response. Treated larvae required several 
days longer than controls to reach a comparable premeta 
morphic stage [burroWing-digging according to Webb and 
Dahlman, 2 Arch. Insect Biochem. Physiol. 131 (1985)]. 
Reductions in fat body proliferation similar to those seen in 
parasitiZed larvae Were observed in larvae treated With either 
1 LE of teratocytes, or With 2 or 4 LEs of crude TSP. 
Proliferation of perivisceral fat body Weights from larvae 
treated With either teratocytes or crude TSP Was signi?cantly 
reduced, in a dose dependent manner, When compared to 
controls. Both light- and transmission-electron microscopy 
observations revealed cytological differences in fat body 
tissues of larvae injected With either teratocytes or crude 
TSP from the condition observed in parasitiZed larvae and 
noninjected controls. Gross dissection of perivisceral fat 
body from parasitiZed, teratocyte-injected and TSP-injected 
larvae shoWed tissue much less developed and differed 
considerably in appearance from controls. Observed differ 
ences included reduced siZe and/or number of lipid bodies 
and qualitative and quantitative changes in other cytoplas 
mic organelles [Zhang et al., 43 J. Insect Physiol. 577 
(1997)]. 
Example 8—Expression of Teratocyte Secretory 
Protein (TSP) Gene in Transgenic Plants Renders 
Resistance to Insect Feeding 
Experimental Protocol: 
Plant and enZymes: Tobacco plants (Nicotiana tabacum 
CV Samsun NN) Were used for plant transformation. Trans 
genic tobacco seeds (R1 and R2 progeny) Were germinated 
in the presence of Kanamycin (220 pg/mL) for selecting 
transformed seedlings. Restriction enZymes, DNA modify 
ing enZymes, and DNA and RNA isolation kits Were pur 
chased from commercial sources from Gibco-BRL Life 
Technologies (Rockville, Md.) and used according to the 
manufactures’ speci?cations. Nitrocellulose membranes for 
hybridiZation analysis Were obtained from Schleicher & 
Schuell (Keene, 
Construction of plant expression vectors pK117, pK118 
and pK119: The plasmid pVL1392-TSPhis containing the 
cDNA gene of teratocyte secretory protein (TSP) from 
Microplitis croceipes, a member of the Braconidae Wasp 
family, Was used as starting genetic material. The DNA 
fragments corresponding to the coding sequence of TSP With 
and Without its signal peptide (TSPdSP) Were isolated by 
PCR ampli?cation from the plasmid pVL1392-TSPhis. For 
PCR reaction, to isolate TSP With its signal peptide, the 
folloWing primers Were used: a 39-mer forWard primer, 
(named 5‘TSP#88) (SEQ ID NO 7), 5‘-d(GCGGG 
CTCGAGACCATGGGTCCATCCAAAATTTTAATT)-3‘ 
With 18nt complementary to the 5‘ end of the TSP gene 














XhoI and NcoI restriction cleavage sites (underlined) and 
translation initiation codon (bold); a 42-mer reverse primer, 
(named 3‘TSP#90) (SEQ ID NO 10) 5‘-d(ATGCAG 
GGGCTCTTAG 
GTCGACCCGGGCCCTTTTTTCTTGTA)-3‘ With 18 nt 
complementary to the 3‘ end of the TSP gene (amino acid 
coordinates #126 to 131 of TSP), ?anked With tWo restric 
tion sites SalI and SstI and a stop codon (bold). These 
restriction sites Were introduced into the PCR ampli?ed TSP 
gene fragment for cloning facilities in plant expression 
vectors. 
For PCR ampli?cation of the TSP gene Without its signal 
peptide a 39-mer forWard primer: (named 5‘TSPdSP#89) 
(SEQ ID NO 8), 5‘-d(GCGGGCTCGAG AACCATGGGT 
CATCCATTCGATTTTTCT)-3‘ With 18 nt complementary 
to the 5‘ end of the TSP gene (amino acid coordinates #23 to 
28 of TSP), and XhoI and NcoI sites (underlined) and a 
translation initiation codon (bold); and the reverse primer, 
3‘TSP#90 described above Were used. The PCR ampli?ca 
tion Was carried out for 30 cycles under the folloWing 
standard condition: denaturation (92° C. for 1 min), anneal 
ing (550 C. for 1 min), synthesis (720 C. for 2 min). The PCR 
generated TSP gene fragment, With and Without the signal 
peptide, Were digested With XhoI and SstI, gel puri?ed and 
cloned into the corresponding sites of pBS (KS+) for DNA 
sequencing. The resulting plasmids Were named pBT and 
pBdT, respectively. Before use, all PCR products Were 
sequenced by dideoxy chain terminator method [Sanger et 
al., 74 Proc. Nat’l. Acad. Sci. USA 5463 (1997)] using a 
synthetic primer. The TSP fragments With and Without the 
signal peptide Were isolated after restriction digestion of 
pBT and pBdT respectively With NcoI and SstI, the frag 
ments Were gel puri?ed and cloned into the corresponding 
sites of pBS-AlMV5‘ [Maiti et al., 90 Proc. Nat’lAcad. Sci. 
USA 6110 (1993)] Which contains the 5‘ut7 untranslated 
region of AlMV RNA 4. The resulting plasmids Were 
designated as pB5‘T and pB5‘dT respectively, have the 
general structure: 5‘-XhoI-AlMV-RNA4—5‘untranslated 
region-NcoI-TSP gene fragment-SalI-SstI-3‘. The XhoI-SstI 
fragment of TSP With and Without the signal peptide Was 
cloned separately into the corresponding sites of the expres 
sion vector pKLP36 [Maiti and Shepherd, 244 Biochem. 
Biophys. Res. Comm. 440 (1998); Maiti and Shepherd, US. 
Pat. No. , 5,850,019 (1998)]. The TSP gene is under the 
control of a modi?ed PC1SV full-length transcript promoter. 
The resulting expression vectors Were designated as pKT117 
(Which contains TSP With the signal peptide) and pKT118 
Which contains TSP Without the signal peptide; see FIG. 2). 
Construction ofpKT119: The coding sequence 
(corresponding to amino acid coordinates 23 to 131) of TSP 
Without its signal peptide Was isolated by PCR ampli?cation 
using pVL1392-TSPhis as a template. In PCR reaction the 
appropriately designed folloWing primers Were used. The 
forWard primer (5‘TSP#140) (SEQ ID NO 9), 5‘-d(GCGGG 
CTCGAGAACC?GGT 
GGATCCCNFCCATTCGATTTTTCT)-3‘ With 18 nt 
complementary to the 5‘ end (italic) of the TSP gene (amino 
acid coordinates #23 to 28 of TSP gene), along With XhoI, 
NcoI and BamHI sites (underlined) and a translation initia 
tion codon (bold); and the 42-mer reverse primer 3‘TSP#90 
described above Were used. The PCR ampli?ed fragment 
Was gel puri?ed, digested With XhoI and SstI and cloned into 
the corresponding sites of pBS(KS+). The resulting plasmid 
Was designated as pBdT2. The NcoI to SstI fragment con 
taining TSP Without the signal peptide Was restricted from 
pBdT2, gel puri?ed and cloned into the corresponding sites 
of pBS-AlMV5‘ [Maiti et al., 90 Proc. Nat’lAcad. Sci. USA 
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6110 (1993)] in order to incorporate the 5‘ut7 region of 
AlMV RNA4 as described above. The resulting plasmid was 
named as pB5‘dT2. A 30 amino acid long transit sequence 
from PR1b gene Was isolated from pBSAPM (a plasmid 
containing PR 1b transit sequence) by PCR arnpli?cation 
using appropriately designed primers to insert NcoI sites at 
the 5‘ end, and BarnHI site at the 3‘ end. The PCR product 
for transit peptide PR1b Was gel puri?ed and digested With 
NcoI and BarnHI and inserted into the corresponding sites of 
pB5‘dT2. The Xhol to SstI fragment from the resulting 
plasrnid pB5‘RdT2 Was cloned into the corresponding sites 
of plant expression vector pKLP36 (Maiti and Shepherd 
supra, supra). The resulting plant expression vector Was 
designated as pKT119. 
Plant transformation and analysis of transgenic plants: 
The plant expression vectors Were introduced into Agrobac 
terium tumefaciens strain C58C1:pGV3850 by triparental 
mating and tobacco (Nicotiana tabacum CV Sarnsun NN) 
was transformed With the engineered Agrobacteriurn as 
described earlier [Maiti et al., 90 Proc. Nat’lAcaa'. Sci. USA 
6110 (1993)]. 
PCR analysis: The integration of TSP gene in the genome 
of transgenic plants (R1 and R2 progeny) Was detected by 
PCR arnpli?cation using appropriately designed prirners 
speci?c for TSP or TSPASP (TSP Without signal peptide) 
gene sequence. The speci?city of each PCR product Was 
analyZed by Southern hybridiZation With a TSP probe. 
RNA isolation, RNA dot blot and Northern analysis: Total 
RNA Was isolated from the transgenic tobacco seedlings (R2 
progeny) developed With pKT117 and pKT118 and untrans 
forrned control seedlings (Sarnsun NN). Transforrned seed 
lings developed With pKLP36GUS [Maiti and Shepherd, 
244 Biochem. Biophys. Res. Comm. 440 (1998)] Was used as 
a vector control. Total RNA Was isolated With guanidine 
thiocyanate solution as described earlier [Maiti et al., 57 
Virus Research 113 (1998)]. Procedures folloWed for RNA 
dot blot and Northern analysis have been described in details 
(Dey and Maiti, 40 Plant Mol. Biology, 71 (1999). 
Western blot analysis: Protein Was extracted from leaves 
of transformed plants With TSP constructs and transformed 
plants With GUS construct as vector control, and nontrans 
forrned control plants. Leaf tissue was homogenized in 
extraction buffer (0.0625M Tris-HCl pH6.8, 10% glycerol, 
2% SDS, 10% 2-rnercaptoethanol), boiled for 5 min, and 
centrifuged at 12000><g for 10 min. Total soluble leaf pro 
teins (25 pg) Were separated on a 12.5% SDS-PAGE, 
transferred to nitrocellulose, and probed With the antiserum 
raised against the synthetic peptide of TSP. Blots Were 
developed With chernilurninescence reagents from a Pierce 
kit described above. 
Results from the Molecular Analysis of Transgenic Plants: 
The chirneric TSP gene With and Without its signal peptide 
Were introduced into tobacco plants by Agrobacteriurn 
rnediated transformation as described earlier [Maiti et al., 90 
Proc. Nat’l Acad. Sci. USA 6110 (1993)]. The coding 
sequence of TSP gene Was placed under the control of 
rnodi?ed PC1SV FLt promoter and rbcs E9 terrninating 
sequence in the plant expression vector pKLP36 [Maiti and 
Shepherd, US. Pat. No. 5,850,019 (1998)]. The 5‘ ends of 
the TSP genes Were fused to the untranslated leader 
sequence of AlMV RNA 4 sequence to enhance the trans 
lation of rnRNA. The upstream PC1SV FLt promoter was 
rnodi?ed With the double enhancer domain in order to 
stimulate the transcription of chimeric gene in plants [Maiti 
and Shepherd, US. Pat. No. 5,850,019 (1998)]. Transgenic 
plants derived from each transforrnent Were assayed for the 














RNA dot blot and Northern blot and irnrnunobloting analy 
sis. Transgene Were stably integrated as shoWn by PCR 
analysis for R1 and R2 progeny seedlings (data not shoWn). 
Accumulation of TSP rnRNA in leaf of transgenic plants 
Were evaluated by RNA dot blot and Northern analysis (FIG. 
3). The Northern analysis of total RNA isolated from 
hornoZygous lines (R2 progeny/3rd generation) shoWed the 
expected siZe of TSP and TSPASP transcripts (FIG. 3). 
Proper Mendelian segregation of the KanR marker gene 
Was observed. HornoZygous tobacco independent lines 
(based on KanR marker gene) expressing TSP and TSPASP 
Were taken for insect-bioassay. 
Exarnple 9—Insecticidal Activity of Transgenic 
Tobacco Leaf Tissue 
Insect bioassays were performed on hornologous trans 
genic lines (R2 progeny) transgenic tobacco plants trans 
formed With the constructs pKT117 and pKT118 containing 
the TSP With and Without its signal peptide, respectively, 
Were tested for insect tolerance by feeding excised leaves to 
neonate lepidopteran larvae, tobacco budWorrn (H. 
verescens) and tobacco hornWorrn (Manduca sexta). 
The plants to be tested Were gerrninated from seeds on 
nutrient agar plates, then transferred to nutrient agar placed 
in the bottom of sterile 6><6><10 cm tall plastic boxes Where 
they Were groWn under arti?cial light for approximately four 
Weeks. By this time the plants has attained heights of 
approximately 10 cm. Leaf material was harvested from 
these plants, as needed, to supply fresh tissue to each insect 
in the bioassay. 
The assay arena consisted of a 10x50 mm tightly sealed 
plastic petri dish containing a 4.25 cm disk of Whatrnan #1 
?lter paper, moistened with 100 pL of Water. Initially, an 
approximately 2.5 cm2 portion of leaf tissue was removed 
from the plant and placed on the moist ?lter paper. To each 
dish Was added a single neonate H. verescens larvae. Ten 
larvae Were used for each treatment. On the third day after 
the test Was initiated, each larva Was observed under a 
dissecting binocular microscope and the developmental sta 
diurn Was recorded as either being actively feeding or in the 
prernolt or pharate stage of the next stadiurn. Additional leaf 
material was added as needed. The Width of the head capsule 
shed after each larval ecdysis was measured at the Widest 
point. Beginning on the ?fth day of the test, each larvae Was 
Weighed to the nearest 0.1 mg. Also on the ?fth day, the 
contents of the dish and ?lter paper Was replaced. This time 
the paper Was moistened with 75 ML of Water because the 
mass of leaf tissue added had increased to the point that less 
supplernental Water Was required to maintain leaf turgidity. 
The test was terminated on the seventh day, all larvae Were 
froZen and the ultimate head capsule Widths subsequently 
determined. 
A total of 22 transforrned tobacco lines have been tested; 
11 containing the TSP gene With the signal peptide and 11 
containing the TSP gene Without the signal peptide. Three 
different sets of controls Were usually included With each 
group of transformed plants that Were tested. These Were 
untransforrned tobacco, cultivar Sarnsun NN; plants trans 
formed With pKLP36GUS, a gene With no knoWn insecti 
cidal activity [Maiti and Shepherd, 244 Biochem. Biophys 
Res. Comm. 440 (1998)]; and arti?cial diet. 
Three different parameters Were used to assess insecti 
cidal activity. 1). Weighted values for time to speci?c 
developmental stages for days 3, 4, 5, 6 and 7 of the 
experiment. Even in standardiZed assays, not all larvae feed 
and groW at the same rate. Therefore, each developrnental 
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stage (instar) Was assigned a numerical score as a useful Way 
to statistically evaluate delayed development of H. verescens 
larvae. The following values Were assigned: 2nd instar=1, 
premolt 2nd instar=2, 3rd instar=3, premolt 3rd instar=4, 4th 
in premolt 4th instar=6, 5th instar=7. 2). Mean Weight of 
larvae on days 5, 6 and 7 of the experiment. 3). Mean Width 
of head capsule for each instar. The data Was analyZed 
With a one-Way AOV and LSD (T) pairWise comparisons of 
means using a Statistix 4.1 program. 
Of the 22 transformed lines tested, six yielded signi? 
cantly loWer values than the GUS control With at least one 
of the three parameters measured. An additional four lines 
shoWed trends that may or may not be statistically different 
from GUS controls. Table 2 shoWs that after a seven day 
feeding trial With selected lines the average developmental 
stage Was approximately one rank less than those feeding on 
the GUS transformed control. The mean Weight gained by 
larvae in these tests had substantial standard error and only 
one of the transformed lines yielded signi?cantly reduced 
Weight gain. In three of the lines, head capsule Widths Were 
signi?cantly smaller than controls in at least some instars, an 
indication of less conversion of ingested food to body mass. 
Four of the six most promising lines Were transformed 
Without the signal peptide. HoWever, one of the transformed 
lines With the signal peptide appears to be one of the better 
of the group. 
Because of limited plant material, only a feW tests With 
larvae of Manduca sexta Were conducted. The test arena Was 
that same used for H. verescens but because neonate M. 
sexta larvae are much larger than H. verescens they consume 
much more leaf material. It appeared that M. sexta Was much 
more sensitive to the TSP gene expressed in the transformed 
plants than H. verescens (Table 3). Lines containing the TSP 
gene Without the signal peptide Were the most effective. 
Even though the number of tests Was very small, mortality, 
as Well as inhibition of groWth and development, Was 
evident Within ?ve days after placement on the transformed 
plant material. 
Conclusion 
In conclusion, the cDNA encoding TSP, When puri?ed 









thesis in organ cultures, rabbit reticulocyte lysate assays and 
Wheat germ extract assays. Inhibition of translation Was 
similar to that observed When the 30-kD TSP fraction Was 
assayed. In vivo studies shoWed that injections of crude TSP 
caused inhibition of groWth, developmental arrest and vari 
ous physiological changes similar to those caused by injec 
tions of teratocytes or parasitiZation by the M. croceipes 
Wasp. 
The TSP gene, With and Without the signal peptide, has 
been expressed in transgenic tobacco plants. Heliothis larvae 
offered some lines of these transgenic tobacco plants greW 
and developed more sloWly than controls. Manduca larvae 
also greW more sloWly and experienced higher mortality 
than larvae fed control plants. 
Although the present invention has been fully described 
herein, it is to be noted that various changes and modi?ca 
tions are apparent to those skilled in the art. Such changes 
and modi?cations are to be understood as included Within 
the scope of the present invention as de?ned by the 
appended claims. 
TABLE 1 
Sequence listing brief description 
SEQ ID NO Description of Sequence 
TSP cDNA sequence (Without signal) 
TSP amino acid sequence (Without signal) 
TSP cDNA sequence (With signal) 






Response of tobacco budWorm to transgenic plants expressing TSP gene With and 
Without its signal peptide. Response of neonate H. virescens larvae after feeding seven 
days on transgenic tobacco plants lines. 
Weighted Stagea Mean Weight % Weight 
Plant Line 1 SE. LSDb 1 SE. (mg) LSD Reduction 
GUS (Control) 5.9 1 0.3 A 78.2 1 10.5 A 0 
pKLP36GUS(3)R1#2 
7311 5.3 1 0.2 AB 68.0 1 8.5 A 13 
117(3)R1#3 
71019 4.8 1 0.6 B 55.6 1 22.8 A 28.9 
117(10)R1#9 
8115 5.0 1 0.0 B 59.5 1 10.0 A 23.9 
118(1)R1#5 
8615 4.6 1 0.8 B 47.3 1 21.1 B 39.5 
118(6)R1#5 
8711 5.2 1 0.2 AB 74.9 1 10.8 A 4.2 
118(7)R1#1 
8816 5.1 1 0.4 B 69.8 1 11.8 A 11.8 
118(8)R1#6 
aEach developmental stage assigned a numerical value With larger values indicating 
greater developmental rate. 
LSD = Least Signi?cant Difference analysis of mean separation. Values followed by the 
same letter are not signi?cantly different (P 2 0.05). 
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TABLE 3 
Response of tobacco hornWorrn to transgenic plants expressing TSP gene 
With and Without its signal peptide. Response of neonate M. sexta larvae 
after feeding ?ve days on transgenic tobacco plant lines. 
Mean Weight 
Plant Line 1 SE. (rng) LSDa % Mortality at 5 Days 
GUS (Control) 31.8 1 5.2 A O 
pKLP36GUS(3)R1#3 10 
7311 29.4 1 11.1 AB 0 
117(3)R1#1 
8115 12.6 1 2.5 BC 50 
118(1)R1#5 
8711 9.7 1 3.3 C 25 
118(7)R1#1 15 
8816 8.4 1 1.3 C 50 
118(8)R1#6 
aLSD = least Signi?cant Difference analysis of mean separation. Values 
followed by the same letter are not signi?cantly different (P 2 0.05). 
SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: l0 
<2 10> SEQ ID NO 1 
<2ll> LENGTH: 320 
<2l3> ORGANISM: Microplitis sp. 
<400> SEQUENCE: l 
ccattcgatt tttctgatga tggaaatcaa agctgtgctc cggcttcagg aatctgccat 60 
cgagtaggat tagaaattac caaaccgtgt tgtaataaat tcgatcgttg tttcgcttca 120 
gtatctgaac ccgtgtctcg ttgtggtggg acggattact cggtagcagt tgtaacagtt 180 
ctttcgattg taccaaagtt cagggtgcaa cttgtgaaaa cgggatatgt acttgcggaa 240 
aagatgctac tgagtacaca agacacagat gtaaaccaaa tcacatgtcc ccgaaagtta 300 
catggtacaa caaaaaatga 320 
<2ll> LENGTH: 106 
<2l2> TYPE: PRT 
<2l3> ORGANISM: Microplitis sp. 
<400> SEQUENCE: 2 
Pro Phe Asp Phe Ser Asp Asp Gly Asn Gln Ser Cys Ala Pro Ala Ser 
1 5 l0 l5 
Gly Ile Cys His Arg Val Gly Leu Glu Ile Thr Lys Pro Cys Cys Asn 
20 25 30 
Lys Phe Asp Arg Cys Phe Ala Ser Val Ser Glu Pro Val Ser Arg Cys 
35 40 45 
Gly Gly Asp Gly Leu Leu Gly Ser Ser Cys Asn Ser Ser Phe Asp Cys 
50 55 60 
Thr Lys Val Gln Gly Ala Thr Cys Glu Asn Gly Ile Cys Thr Cys Gly 
65 70 75 80 
Lys Asp Ala Thr Glu Tyr Thr Arg His Arg Cys Lys Pro Asn His Met 
85 9O 95 
Ser Pro Lys Val Thr Trp Tyr Asn Lys Lys 
100 105 
25 
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-oontinued 
<2 10> SEQ ID NO 3 
<2ll> LENGTH: 389 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Microplitis sp. 
<400> SEQUENCE: 3 
atgccatcca aaattttaat ttcactcgga atatttctaa ctatttatgt tagttatata 60 
tccgctcatc cattcgattt ttctgatgat ggaaatcaaa gctgtgctcc ggcttcagga 120 
atctgccatc gagtaggatt agaaattacc aaaccgtgtt gtaataaatt cgatcgttgt 180 
ttcgcttcag tatctgaacc cgtgtctcgt tgtggtggga cggattactc ggtagcagtt 240 
gtaacagttc tttcgattgt accaaagttc agggtgcaac ttgtgaaaac gggatatgta 300 
cttgcggaaa agatgctact gagtacacaa gacacagatg taaaccaaat cacatgtccc 360 
cgaaagttac atggtacaac aaaaaatga 389 
<2 10> SEQ ID NO 4 
<2ll> LENGTH: 129 
<2 12> TYPE: PRT 
<2 13> ORGANISM: Microplitis sp. 
<400> SEQUENCE: 4 
Met Pro Ser Lys Ile Leu Ile Ser Leu Gly Ile Phe Leu Thr Ile Tyr 
l 5 l0 15 
Val Ser Tyr Ile Ser Ala His Pro Phe Asp Phe Ser Asp Asp Gly Asn 
20 25 30 
Gln Ser Cys Ala Pro Ala Ser Gly Ile Cys His Arg Val Gly Leu Glu 
35 40 45 
Ile Thr Lys Pro Cys Cys Asn Lys Phe Asp Arg Cys Phe Ala Ser Val 
50 55 60 
Ser Glu Pro Val Ser Arg Cys Gly Gly Asp Gly Leu Leu Gly Ser Ser 
65 70 75 80 
Cys Asn Ser Ser Phe Asp Cys Thr Lys Val Gln Gly Ala Thr Cys Glu 
85 90 95 
Asn Gly Ile Cys Thr Cys Gly Lys Asp Ala Thr Glu Tyr Thr Arg His 
100 105 110 
Arg Cys Lys Pro Asn His Met Ser Pro Lys Val Thr Trp Tyr Asn Lys 
115 120 125 
Lys 
<2 10> SEQ ID NO 5 
<2ll> LENGTH: 17 
<2 12> TYPE: PRT 
<2 13> ORGANISM: Microplitis sp. 
<220> FEATURE: 
<221> NAME/KEY: UNSURE 
<222> LOCATION: (6)..(9) 
<223> OTHER INFORMATION: X = unspecified or any amino acid 
<400> SEQUENCE: 5 





SEQ ID NO 6 
LENGTH: 
ORGANISM: Microplitis sp. 
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-continued 
<220> FEATURE: 
<221> NAME/KEY: UNSURE 
<222> LOCATION: (9)..(9) 
<223> OTHER INFORMATION: X = unspecified or any amino acid 
<400> SEQUENCE: 6 
Ala Ala Arg Cys Ala Tyr Cys Cys Xaa Th]: Th]: Tyr Gly Ala Tyr Th]: 
1 5 10 
Th]: 
<2 10> SEQ ID NO 7 
<2ll> LENGTH: 38 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Microplitis sp. 
<400> SEQUENCE: 7 
gcgggctcga gaccatgggt ccatccaaaa ttttaatt 
SEQ ID NO 8 
LENGTH: 39 
TYPE: DNA 
ORGANISM: Microplitis sp. 
<400> SEQUENCE: 8 
gcgggctcga gaaccatggg tcatccattc gatttttct 
SEQ ID NO 9 
LENGTH: 45 
TYPE: DNA 
ORGANISM: Microplitis sp. 
<400> SEQUENCE: 9 
gcgggctcga gaaccatggg tggatcccat ccattcgatt tttct 
SEQ ID NO 10 
LENGTH: 42 
TYPE: DNA 
ORGANISM: Microplitis sp. 
<400> SEQUENCE: l0 







1. An isolated teratocyte secretory protein (TSP) nucleic 
acid, wherein said nucleic acid is selected from the group 
consisting of: 
(a) a nucleic acid selected from the group consisting of: 
SEQ ID NO 1; and SEQ ID NO 3, and 
(b) a nucleic acid molecule fully complementary to a 
nucleic acid molecule selected from the group consist 
ing of: SEQ ID NO 1; and SEQ ID NO 3. 
2. A vector comprising a nucleic acid of claim 1. 
3. A vector of claim 2, Wherein said vector further 




4. Avector of claim 3, Wherein said inducible promoter is 
tightly regulated. 
5. A recombinant plant cell comprising a vector of claim 
3. 
6. A recombinant seed comprising a vector of claim 3. 
7. A recombinant plant embryo comprising a vector of 
claim 3. 
8. A recombinant plant comprising a vector of claim 3. 
9. A recombinant plant of claim 8, Wherein said plant is 
selected from the group consisting of tobacco, cotton, corn, 
soybeans, and tomatoes. 
